291
Views
20
CrossRef citations to date
0
Altmetric
Research Paper

Prevention of KLF4-mediated tumor initiation and malignant transformation by UAB30 rexinoid

Pages 289-298 | Published online: 01 Feb 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chen-Chung Lin, Ling-Zhi Liu, Joseph B. Addison, William F. Wonderlin, Alexey V. Ivanov & J. Michael Ruppert. (2011) A KLF4–miRNA-206 Autoregulatory Feedback Loop Can Promote or Inhibit Protein Translation Depending upon Cell Context. Molecular and Cellular Biology 31:12, pages 2513-2527.
Read now

Articles from other publishers (19)

Jill M. Kolesar, Shannon Andrews, Heather Green, Tom C. Havighurst, Barbara W. Wollmer, Katina DeShong, Douglas E. Laux, Helen Krontiras, Donald D. Muccio, KyungMann Kim, Clinton J. Grubbs, Margaret G. House, Howard L. Parnes, Brandy M. Heckman-Stoddard & Howard H. Bailey. (2019) A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers. Cancer Prevention Research 12:12, pages 903-912.
Crossref
Chu-Fang Chou, Yu-Hua Hsieh, Clinton J. Grubbs, Venkatram R. Atigadda, James A. Mobley, Reinhard Dummer, Donald D. Muccio, Isao Eto, Craig A. Elmets, W. Timothy Garvey & Pi-Ling Chang. (2018) The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis. Journal of Dermatological Science 90:3, pages 343-356.
Crossref
Susan M. Corley, Shan-Yuan Tsai, Marc R. Wilkins & Cynthia Shannon Weickert. (2016) Transcriptomic Analysis Shows Decreased Cortical Expression of NR4A1, NR4A2 and RXRB in Schizophrenia and Provides Evidence for Nuclear Receptor Dysregulation. PLOS ONE 11:12, pages e0166944.
Crossref
Wei-Cheng Tseng, Cheng-Wei Chuang, Muh-Hwa Yang, Chin-Chen Pan & Der-Cherng Tarng. (2016) Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition. Urologic Oncology: Seminars and Original Investigations 34:11, pages 485.e15-485.e24.
Crossref
Alicia M. Waters, Jerry E. Stewart, Venkatram R. Atigadda, Elizabeth Mroczek-Musulman, Donald D. Muccio, Clinton J. Grubbs & Elizabeth A. Beierle. (2016) Preclinical Evaluation of UAB30 in Pediatric Renal and Hepatic Malignancies. Molecular Cancer Therapeutics 15:5, pages 911-921.
Crossref
Lizhi Wu, Sandeep C. Chaudhary, Venkatram R. Atigadda, Olga V. Belyaeva, Steven R. Harville, Craig A. Elmets, Donald D. Muccio, Mohammad Athar & Natalia Y. Kedishvili. (2016) Retinoid X Receptor Agonists Upregulate Genes Responsible for the Biosynthesis of All-Trans-Retinoic Acid in Human Epidermis. PLOS ONE 11:4, pages e0153556.
Crossref
Venkatram R. Atigadda, Gang Xia, Anil Deshpande, Lizhi Wu, Natalia Kedishvili, Craig D. Smith, Helen Krontiras, Kirby I. Bland, Clinton J. Grubbs, Wayne J. Brouillette & Donald D. Muccio. (2015) Conformationally Defined Rexinoids and Their Efficacy in the Prevention of Mammary Cancers. Journal of Medicinal Chemistry 58:19, pages 7763-7774.
Crossref
Alicia M. Waters, Jerry E. Stewart, Venkatram R. Atigadda, Elizabeth Mroczek-Musulman, Donald D. Muccio, Clinton J. Grubbs & Elizabeth A. Beierle. (2015) Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma. Molecular Cancer Therapeutics 14:7, pages 1559-1569.
Crossref
Alessandra di Masi, Loris Leboffe, Elisabetta De Marinis, Francesca Pagano, Laura Cicconi, Cécile Rochette-Egly, Francesco Lo-Coco, Paolo Ascenzi & Clara Nervi. (2015) Retinoic acid receptors: From molecular mechanisms to cancer therapy. Molecular Aspects of Medicine 41, pages 1-115.
Crossref
Venkatram R. Atigadda, Gang Xia, Anil Desphande, LeeAnn J. Boerma, Susan Lobo-Ruppert, Clinton J. Grubbs, Craig D. Smith, Wayne J. Brouillette & Donald D. Muccio. (2014) Methyl Substitution of a Rexinoid Agonist Improves Potency and Reveals Site of Lipid Toxicity. Journal of Medicinal Chemistry 57:12, pages 5370-5380.
Crossref
LeeAnn J. Boerma, Gang Xia, Cheng Qui, Bryan D. Cox, Michael J. Chalmers, Craig D. Smith, Susan Lobo-Ruppert, Patrick R. Griffin, Donald D. Muccio & Matthew B. Renfrow. (2014) Defining the Communication between Agonist and Coactivator Binding in the Retinoid X Receptor α Ligand Binding Domain. Journal of Biological Chemistry 289:2, pages 814-826.
Crossref
Anil Desphande, Gang Xia, LeeAnn J. Boerma, Kimberly K. Vines, Venkatram R. Atigadda, Susan Lobo-Ruppert, Clinton J. Grubbs, Fariba L. Moeinpour, Craig D. Smith, Konstantin Christov, Wayne J. Brouillette & Donald D. Muccio. (2014) Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention. Bioorganic & Medicinal Chemistry 22:1, pages 178-185.
Crossref
Stephen Hyter & Arup K. Indra. (2013) Nuclear hormone receptor functions in keratinocyte and melanocyte homeostasis, epidermal carcinogenesis and melanomagenesis. FEBS Letters 587:6, pages 529-541.
Crossref
Marcia I. Dawson & Zebin Xia. (2012) The retinoid X receptors and their ligands. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1821:1, pages 21-56.
Crossref
Jill M. Kolesar, Ryan Hoel, Marcia Pomplun, Tom Havighurst, Jeanne Stublaski, Barbara Wollmer, Helen Krontiras, Wayne Brouillette, Donald Muccio, KyungMann Kim, Clinton J. Grubbs & Howard E. Bailey. (2010) A Pilot, First-in-Human, Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers. Cancer Prevention Research 3:12, pages 1565-1570.
Crossref
Beth B. McConnell & Vincent W. Yang. (2010) Mammalian Krüppel-Like Factors in Health and Diseases. Physiological Reviews 90:4, pages 1337-1381.
Crossref
Nathan Bushue & Yu-Jui Yvonne Wan. (2010) Retinoid pathway and cancer therapeutics. Advanced Drug Delivery Reviews 62:13, pages 1285-1298.
Crossref
Donald J. AbrahamMarcia I. Dawson. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 369 546 .
Izet M. Kapetanovic, Thomas L. Horn, William D. Johnson, Michael J. Cwik, Carol J. Detrisac & David L. McCormick. (2010) Murine Oncogenicity and Pharmacokinetics Studies of 9- cis -UAB30, an RXR Agonist, for Breast Cancer Chemoprevention . International Journal of Toxicology 29:2, pages 157-164.
Crossref